iCellate

Stockholm, Sweden

iCellate is a Swedish research and development company focused on cancer research and detection products.

$1.9M raised

May 2023

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has iCellate raised?

iCellate has raised $1.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2023.

Who are iCellate's investors?

iCellate's investors include Sting.

Where is iCellate headquartered?

iCellate is headquartered in Stockholm, Sweden.

What does iCellate do?

iCellate is a Swedish research and development company focused on cancer research and detection products.

What stage is iCellate at?

iCellate is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 19, 2023.

MLA

"iCellate — Funding & Investors." VCBacked, May 19, 2023, https://www.vcbacked.co/company/icellate. Accessed July 2, 2026.

APA

VCBacked. (2023). iCellate — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/icellate

Wikipedia (cite web)

{{cite web |title=iCellate — Funding & Investors |url=https://www.vcbacked.co/company/icellate |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 19, 2023.